Elif Hindié
Elif Hindié
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elif Hindié has a total of 215 co-authors. Here are the top co-authors by number of shared publications:
- Clément Morgat
Nuclear Medicine & Radiopharmacy Department, Bordeaux University Hospital, Bordeaux, France
15 shared publications - David Groheux
Department of Nuclear Medicine, Saint-Louis Hospital, Paris, France
9 shared publications - Charles Mesguich
CHU de Bordeaux, Service de Médecine nucléaire
7 shared publications - David Taïeb
Département de médecine nucléaire, hôpital de la Timone, AP-HM, CERIMED, université Aix-Marseille, 264, rue Saint-Pierre, 13385 Marseille, France
6 shared publications Paolo Zanotti-Fregonara
Houston Methodist Research Institute, United States
6 shared publications- Christophe Champion
Laboratoire de Physique Moléculaire et des Collisions, ICPMB (FR CNRS 2843), Institut de Physique, Université Paul Verlaine-Metz, Metz cedex 3, France
4 shared publications
Latest Publications
- Open Access
- 17 September 2026
- Published by Elsevier in Journal of Visceral Surgery
Recurrent or persistent primary hyperparathyroidism, parathyromatosis
- 17 September 2026
- Published by Elsevier in Journal of Visceral Surgery
Open AccessRecurrent or persistent primary hyperparathyroidism, parathyromatosis
- 29 June 2026
- Published by Elsevier in The Lancet Oncology
- Vol. 27 (7) , e319
Terbium-161 might be superior to lutetium-177 for oligometastases
- 29 June 2026
- Published by Elsevier in The Lancet Oncology
- Vol. 27 (7) , e319
Terbium-161 might be superior to lutetium-177 for oligometastases
- 7 November 2025
- Published by Elsevier in The Lancet
- Vol. 406 (10516) , 2218-2219
CheckMate 8HW and the future of dual immunotherapy
- 7 November 2025
- Published by Elsevier in The Lancet
- Vol. 406 (10516) , 2218-2219
CheckMate 8HW and the future of dual immunotherapy
- 11 August 2025
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 55 (6) , 937-946
GRPR Expression in Metastatic Cancers: A Review of Potential Application of GRPR-Radioligand Therapy
- 11 August 2025
- Published by Elsevier in Seminars in Nuclear Medicine
- Vol. 55 (6) , 937-946
GRPR Expression in Metastatic Cancers: A Review of Potential Application of GRPR-Radioligand Therapy
- 10 June 2025
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 43 (17) , 1942-1947
[ 18 F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer
- 10 June 2025
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 43 (17) , 1942-1947
[ 18 F]-Labeled Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Staging and Restaging Patients With Breast Cancer
- 28 March 2025
- Published by Elsevier in The Lancet
- Vol. 405 (10484) , 1054-1055
Neoadjuvant therapy in HER2-positive breast cancer and interim PET
- 28 March 2025
- Published by Elsevier in The Lancet
- Vol. 405 (10484) , 1054-1055
Neoadjuvant therapy in HER2-positive breast cancer and interim PET
- 27 March 2025
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 66 (5) , 793-794
Synergy Between Radiopharmaceutical Therapy and Immune Response: Deciphering the Underpinning Mechanisms for Future Actions
- 27 March 2025
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 66 (5) , 793-794
Synergy Between Radiopharmaceutical Therapy and Immune Response: Deciphering the Underpinning Mechanisms for Future Actions
- Open Access
- 14 January 2025
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 86 (1) , 101704
Chapter 15: Recurrent or persistent primary hyperparathyroidism, parathyromatosis
- 14 January 2025
- Published by Elsevier in Annales d'Endocrinologie
- Vol. 86 (1) , 101704
Open AccessChapter 15: Recurrent or persistent primary hyperparathyroidism, parathyromatosis
- Open Access
- 13 May 2024
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 51 (9) , 2695-2700
The EANM-SNMMI guideline on the role of [18F]FDG-PET/CT in breast cancer: Important milestones and perspectives for the future
- 13 May 2024
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 51 (9) , 2695-2700
Open AccessThe EANM-SNMMI guideline on the role of [18F]FDG-PET/CT in breast cancer: Important milestones and perspectives for the future
- 21 April 2024
- Published by Elsevier in European Urology
- Vol. 86 (1) , e19-e20
Re: Renu S. Eapen, James P. Buteau, Price Jackson, et al. Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. Eur Urol. 2024;85:217–226
- 21 April 2024
- Published by Elsevier in European Urology
- Vol. 86 (1) , e19-e20
Re: Renu S. Eapen, James P. Buteau, Price Jackson, et al. Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study. Eur Urol. 2024;85:217–226